Abstract
Purpose. Biodegradable poly(isobutylcyanoacrylate) nanocapsules have been recognized as a promising carrier for oral administration of peptides and proteins. In the present study, we investigate the fate of insulin-loaded nanocapsules by fluorescence and transmission electron microscopy (TEM) after intragastric force-feeding to rats.
Methods. Insulin-, Texas-red®-labeled insulin, or gold-labeled insulin-loaded nanocapsules were first characterized. Rats received a single dose of nanocapsules (diameter 60-300 nm, 57 IU insulin/kg) by intragastric force-feeding. After 90 min, ileum was isolated and prepared for fluorescence and transmission electron microscopy.
Results. Nanocapsules were observed on both sides of the gut epithelium and in blood capillaries. In M-cell-free epithelium, apparently intact nanocapsules could be seen in the underlying tissue, suggesting they could cross the epithelium and carry the encapsulated peptide. In M-cell-containing epithelium, nanocapsules appeared degraded in the vicinity of macrophages. It is noteworthy that intestinal absorption of nanocapsules was observed without artifacts forcing the nanocapsules to stay in the gut.
Conclusions. Based on TEM observations, this study shows the intestinal absorption of biodegradable nanocapsules leading to the transport of insulin across the epithelium mucosa. The fate of the nanocapsules appeared different depending on the presence or the absence of M cells in the intestinal epithelium.
Similar content being viewed by others
REFERENCES
A. Leone-Bay, D. R. Paton, and J. J. Weidner. The development of delivery agents that facilitate the oral absorption of macromolecular drugs. Med. Res. Rev. 20:169–186 (2000).
I. Morishita, M. Morishita, K. Takayama, Y. Machida, and T. Nagai. Enteral insulin delivery by microspheres in three different formulations using Eudragit 1100 and S100. Int. J. Pharm. 91:29–37 (1993).
E. Mathiowitz, J. S. Jacob, Y. S. Jong, G. P. Carino, D. E. Chichering, P. Chaturverdi, C. A. Santos, K. Vijayaraghavan, S. Montgomery, M. Basset, and C. Morrel. Biologically erodable microspheres as potential oral drug delivery systems. Nature 386:410–414 (1997).
G. Gwinup, A. N. Elias, and E. S. Domurat. Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules. Gen. Pharm. 22:243–246 (1991).
N. Hussain, V. Jaitley, and A. T. Florence. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. Drug Deliv. Rev. 50:107–142 (2001).
A. T. Florence. The oral absorption of micro-and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14:259–266 (1997).
F. Delie. Evaluation of nano-and microparticle uptake by the gastrointestinal tract. Adv. Drug. Deliv. Rev. 34:221–233 (1998).
D. T. O'Hagan. The intestinal uptake of particles and the implications for drug and antigen delivery. J. Anat. 189:477–482 (1996).
J. H. Eldridge, C. J. Hammond, J. A. Meulbroek, J. K. Staas, R. M. Gilley, and T. R. Tice. Controlled vaccine release in the gut-associated lymphoid tissues. 1. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release 11:205–214 (1990).
P. U. Jani, A. T. Florence, and D. E. McCarthy. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int. J. Pharm. 84:245–252 (1992).
P. G. Jenkins, K. A. Howard, N. W. Blackhall, N. W. Thomas, S. S. Davis, and D. T. O'Hagan. Microparticulate absorption from the rat intestine. J. Control. Release 29:339–350 (1994).
P. U. Jani, D. E. McCarthy, and A. T. Florence. Nanosphere and microsphere uptake via Peyer's patches: observation on the rate of uptake in the rat after a single oral dose. Int. J. Pharm. 86:239–246 (1992).
A. M. Hillery, P. U. Jani, and A. T. Florence. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J. Drug Target. 2:151–156 (1994).
M. Aprahamian, C. Michel, W. Humbert, J. P. Devissaguet, and C. Damgé. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol. Cell 61:69–76 (1987).
C. Damgé, C. Michel, M. Aprahamian, and P. Couvreur. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37:246–251 (1988).
C. Michel, M. Aprahamian, L. Defontaine, P. Couvreur, and C. Damgé. The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats. J. Pharm. Pharmacol. 43:1–5 (1991).
C. Damgé, D. Hillaire-Buys, R. Puech, A. Holizel, C. Michel, and G. Ribes. Effects of orally administered insulin nanocapsules in normal and diabetic dogs. Diab. Nutr. Metab. 8:3–9 (1995).
P. H. Lowe and C. S. Temple. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. J. Pharm. Pharmacol. 46:547–552 (1994).
F. Cournarie, D. Auchere, D. Chevenne, B. Lacour, M. Seiller, and C. Vauthier. Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats. Int. J. Pharm. 242:325–328 (2002).
M. Aboubakar, F. Puisieux, P. Couvreur, and C. Vauthier. Physico-chemical characterization of insulin-loaded poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. Int. J. Pharm. 183:63–66 (1999).
M. Aboubakar, P. Couvreur, H. Pinto-Alphandary, B. Gouritin, B. Lacour, R. Farinotti, F. Puisieux, and C. Vauthier. Insulin-loaded nanocapsules for oral administration: in vitro and in vivo investigation. Drug Dev. Res. 49:109–117 (2000).
S. Mc Clean, E. Prosser, E. Meehan, D. O'Malley, N. Clarke, Z. Ramtoola, and D. Brayden. Binding and uptake of biodegradable poly-DL-lactide micro-and nanoparticles in intestinal epithelia. Eur. J. Pharm. Sci. 6:153–163 (1998).
C. Damgé, C. Michel, M. Aprahamian, P. Couvreur, and J. P. Devissaguet. Nanocapsules as carriers for oral peptide delivery. J. Control. Release 13:233–239 (1990).
C. Damgé, M. Aprahamian, W. Humbert, and M. Pinget. Ileal uptake of polyalkyl-cyanoacrylate nanocapsules in the rat. J. Pharm. Pharmacol. 52:1049–1056 (2000).
L. Szentkuti. Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon. J. Control. Release 46:233–242 (1997).
M. Aboubakar, F. Puisieux, P. Couvreur, M. Deyme, and C. Vauthier. Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. J. Biomed. Material Res. 47:568–576 (1999).
H. Pinto-Alphandary, O. Balland, M. Laurent, A. Andremont, F. Puisieux, and P. Couvreur. Intracellular visualization of ampicillin-loaded nanoparticles in peritoneal macrophages infected in vitro with Salmonella typhimurium. Pharm. Res. 11:38–46 (1994).
A. Dembri, D. Duchêne, and G. Ponchel. The intestinal mucus protects poly(isobutyl-cyanoacrylate) nanoparticles from enzymatic degradation. S. T. P. Pharma Sci. 11:175–180 (2001).
J. Kreuter. Peroral administration of nanoparticles. Adv. Drug. Deliv. Rev. 7:71–86 (1991).
C. Pimienta, F. Chouinard, A. Labib, and V. Lenaerts. Effect of various poloxamer coatings on in vitro adhesion of isohexylcyanoacrylate nanospheres to rat ileal segments under liquid flow. Int. J. Pharm. 80:1–8 (1992).
M. P. Desai, V. Labhasetwar, G. L. Amidon, and R. J. Lévy. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 13:1838–1845 (1996).
R. L. Owen and D. K. Bhalla. Cytochemical analysis of alkaline phosphatase and esterase activities and of lectin-binding and anionic sites in rat and mouse Peyer's patch M cells. Am. J. Anatomy 168:199–212 (1983).
V. Lenaerts, P. Couvreur, D. Christiaens-Leyh, E. Joiris, M. Roland, B. Rollman, and P. Speiser. Degradation of poly(isobutylcyanoacrylate) nanoparticles. Biomaterials 5:65–68 (1984).
J. Kreuter, U. Müller, and K. Munz. Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles. Int. J. Pharm. 55:39–45 (1989).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pinto-Alphandary, H., Aboubakar, M., Jaillard, D. et al. Visualization of Insulin-Loaded Nanocapsules: In Vitro and in Vivo Studies After Oral Administration to Rats. Pharm Res 20, 1071–1084 (2003). https://doi.org/10.1023/A:1024470508758
Issue Date:
DOI: https://doi.org/10.1023/A:1024470508758